- Working at Cross-PURPOSEs to Ending HIV
New England Journal of Medicine, Volume 392, Issue 13, Page 1344-1345, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- A “Hot” Cardiomyopathy
New England Journal of Medicine, Volume 392, Issue 13, Page 1335-1342, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- Clearance of Driver Mutations in Myelofibrosis
New England Journal of Medicine, Volume 392, Issue 13, Page 1348-1349, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- Neonatal Lupus
New England Journal of Medicine, Volume 392, Issue 13, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- Modest Blood Pressure Increase with Age in Adults with Down’s Syndrome
New England Journal of Medicine, Volume 392, Issue 13, Page 1346-1348, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- Malaria
New England Journal of Medicine, Volume 392, Issue 13, Page 1320-1333, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- Cervical Cancer
New England Journal of Medicine, Volume 392, Issue 13, Page 1349-1351, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours
New England Journal of Medicine, Volume 392, Issue 13, Page 1288-1296, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- Association between Wealth and Mortality in the United States and Europe
New England Journal of Medicine, Volume 392, Issue 13, Page 1310-1319, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- The Genetic Architecture of Congenital Diarrhea and Enteropathy
New England Journal of Medicine, Volume 392, Issue 13, Page 1297-1309, April 3, 2025. <br/>
-
View
Pub Date: 2 April 2025 | 4:03 am
- A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 2 April 2025 | 4:00 am
- Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 31 March 2025 | 6:30 am
- Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 30 March 2025 | 9:00 pm
- Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 30 March 2025 | 5:00 am
- Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 30 March 2025 | 1:30 am
- Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 29 March 2025 | 10:00 pm
- Application Overload — A Call to Reduce the Burden of Applying to Medical School
New England Journal of Medicine, Volume 392, Issue 13, Page 1251-1254, April 3, 2025. <br/>
-
View
Pub Date: 29 March 2025 | 6:30 am
- A Letter of Recommendation Regarding Impersonal Personal Statements
New England Journal of Medicine, Volume 392, Issue 13, Page 1257-1259, April 3, 2025. <br/>
-
View
Pub Date: 29 March 2025 | 6:30 am
- Rethinking Shadowing for Aspiring Physicians
New England Journal of Medicine, Volume 392, Issue 13, Page 1249-1251, April 3, 2025. <br/>
-
View
Pub Date: 29 March 2025 | 6:30 am
- Medical School Grading — Is “Good Enough” Good Enough?
New England Journal of Medicine, Volume 392, Issue 13, Page 1254-1257, April 3, 2025. <br/>
-
View
Pub Date: 29 March 2025 | 6:30 am
- Ménétrier’s Disease
New England Journal of Medicine, Volume 392, Issue 13, Page 1334-1334, April 3, 2025. <br/>
-
View
Pub Date: 29 March 2025 | 6:30 am
- Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 29 March 2025 | 1:30 am
- Aortic Stenosis — When Valve Intervention Is Not Enough
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 29 March 2025 | 1:30 am
- Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 29 March 2025 | 1:30 am
- Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
New England Journal of Medicine, Ahead of Print. <br/>
-
View
Pub Date: 28 March 2025 | 9:30 pm
NEJM